References
Nguyen D, Lee SJ, Libby E, Verschraegen C. Rate of thromboembolic events in mesothelioma. Ann Thorac Surg. 2008;85:1032–8.
Rogers 2nd JS, Murgo AJ, Fontana JA, Raich JC. Chemotherapy for breast cancer decreases plasma protein C and protein S. J Clin Oncol. 1988;6:276–81.
Lopes C, Sotto-Mayor R, Teixeira E, Almeida A. Malignant mesothelioma: a ten years experience. Rev Port Pneumol. 2005;11:16–8.
Marcy PY, Magné N, Bentolila F, Drouillard J, Bruneton JN, Descamps B. Superior vena cava obstruction: is stenting necessary? Support Care Cancer. 2001;9:103–7.
Schattner A, Kozack N. A 47-year old man with mesothelioma and neck swelling. CMAJ. 2004;170(4):465.
Isildak M, Guven GS, Emri S. Mesothelioma and venous thrombosis. CMAJ. 2004;171:11.
Matsui H, Nishinaka K, Oda M, Kubori T, Udaka F. Trousseau syndrome due to pleural mesothelioma. Neurologist. 2007;13:205–8.
Farmer CKT, Goldsmith DJA. Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma. Postgrad Med J. 2001;77:333–4.
Nakano T, Chahinian AP, Shinjo M, Tonomura A, Miyake M, Togawa N, et al. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer. 1998;77:907–12.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aktas, B., Uskudar, O., Coban, S. et al. Budd–Chiari Syndrome in Pleural Mesothelioma. J Gastrointest Canc 42, 307–308 (2011). https://doi.org/10.1007/s12029-010-9201-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-010-9201-9